Cancer Research Annual Meeting 2010  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 52, 1886-1890, April 1, 1992]
© 1992 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peters, W. H. M.
Right arrow Articles by Roelofs, H. M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peters, W. H. M.
Right arrow Articles by Roelofs, H. M. J.

Biochemical Characterization of Resistance to Mitoxantrone and Adriamycin in Caco-2 Human Colon Adenocarcinoma Cells: A Possible Role for Glutathione S-Transferases

Wilbert H. M. Peters1 and Hennie M. J. Roelofs

Division of Gastroenterology, University Hospital St Radboud, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands

Cytotoxicity of Adriamycin on human colon adenocarcinoma cell lines was investigated. Concentrations of Adriamycin producing 50% inhibition were very similar in HT29, Sw480, Sw620, and Sw1116 cells, whereas Caco-2 cells were relatively insensitive. As compared to the Sw1116 cell line, Caco-2 cells were also insensitive to mitoxantrone. Sensitivity to cisplatin, 5-fluorouracil, or ethacrynic acid was comparable in both cell lines. To find the mechanism for this mitoxantrone and Adriamycin resistance, several potential Adriamycin-detoxifying systems were characterized and quantified in both Sw1116 and Caco-2 cells. No dramatic differences in glutathione content and expression of both selenium dependent- and independent glutathione peroxidase, UDP-glucuronyltransferase, and cytochrome P-450 were found. However, highly significant differences in glutathione S-transferase activity were present, the expression of both class {pi} and class {alpha} glutathione S-transferases being much higher in the Caco-2 cell line. In addition, a slightly higher content of P-170 glycoprotein was present in the Caco-2 cells. These findings suggest that glutathione S-transferases, and to a lesser extent the P-170 glycoprotein, may be involved in mitoxantrone and Adriamycin resistance of Caco-2 colon carcinoma cells.

1 To whom requests for reprints should be addressed.

Received 7/29/91. Accepted 1/27/92.




This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
L. Couture, J. A. Nash, and J. Turgeon
The ATP-Binding Cassette Transporters and Their Implication in Drug Disposition: A Special Look at the Heart.
Pharmacol. Rev., June 1, 2006; 58(2): 244 - 258.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
S. Maiti and G. Chen
Tamoxifen Induction of Aryl Sulfotransferase and Hydroxysteroid Sulfotransferase in Male and Female Rat Liver and Intestine
Drug Metab. Dispos., May 1, 2003; 31(5): 637 - 644.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
H Hoensch, I Morgenstern, G Petereit, M Siepmann, W H M Peters, H M J Roelofs, and W Kirch
Influence of clinical factors, diet, and drugs on the human upper gastrointestinal glutathione system
Gut, February 1, 2002; 50(2): 235 - 240.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
A. S. Joshi, H. J. Pieniaszek Jr., E. E. Vokes, N. J. Vogelzang, A. F. Davidson, L. E. Richards, M. F. Chai, M. Finizio, and M. J. Ratain
Elimination Pathways of [14C]Losoxantrone in Four Cancer Patients
Drug Metab. Dispos., February 1, 2001; 29(2): 96 - 99.
[Abstract] [Full Text]


Home page
J. Cell Sci.Home page
T Litman, M Brangi, E Hudson, P Fetsch, A Abati, D. Ross, K Miyake, J. Resau, and S. Bates
The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2)
J. Cell Sci., January 6, 2000; 113(11): 2011 - 2021.
[Abstract] [PDF]


Home page
Drug Metab. Dispos.Home page
Z. Zhao, K. A. Koeplinger, T. Peterson, R. A. Conradi, P. S. Burton, A. Suarato, R. L. Heinrikson, and A. G. Tomasselli
Mechanism, Structure-Activity Studies, and Potential Applications of Glutathione S-Transferase-Catalyzed Cleavage of Sulfonamides
Drug Metab. Dispos., September 1, 1999; 27(9): 992 - 998.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
M. O'Driscoll, P. Macpherson, Y.-Z. Xu, and P. Karran
The cytotoxicity of DNA carboxymethylation and methylation by the model carboxymethylating agent azaserine in human cells
Carcinogenesis, September 1, 1999; 20(9): 1855 - 1862.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
T. J. Franklin, V. N. Jacobs, G. Jones, and P. Plé
Human Colorectal Carcinoma Cells In Vitro as a Means to Assess the Metabolism of Analogs of Mycophenolic Acid
Drug Metab. Dispos., March 1, 1997; 25(3): 367 - 370.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1992 by the American Association for Cancer Research.